This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Pressure Biosciences
4/5/2022
Good afternoon, ladies and gentlemen, and welcome to the Pressure Biosciences Q4 and Fiscal Year 2021 Investor Call and Business Update. At this time, all participants have been placed on a listen-only mode, and we'll open the floor for your questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Richard Schumacher, President and CEO. Sir, the floor is yours.
Thank you, John, and thanks, everybody, for joining us for the PBI fourth quarter and full fiscal year Financial Review and Business Update. Before I begin, as always, I'm going to read a cautionary statement. The following remarks may constitute forward-looking statements within the meaning of the Private Securities Litigation Form Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or applied by such forward-looking statements. Such factors include, among others, those detailed from time to time in the company's filings with the Securities and Exchange Commission. We expressly disclaim any obligation or undertaking to release publicly any results, any updates, revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statement is based. So, for today, I'm first pleased to welcome back to the PBI financial review and business update two guys who are super important to the future success of the company whom I talk to every day and work with. Uh, and that, and that's 24 seven and work with, um, um, quite a lot, um, a lot of experience and a lot of help for a guy in, in my position. It's terrific to have people that have been there or there now and have been there before. Um, So I'd certainly like to welcome John Hollister, who's our head of marketing and sales, and Jeff Peterson, who's our board chairman. Welcome, fellas. Good to be here.
Great to join you.
You're reading a preview of the PBIO Q4 2021 earnings call.
Free account.